AZY-29974-49220
5 vaccinations
6 coded responses
24 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 483 / MI
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Cough — Feeling: GoodFree text: Slight increase in the frequency of my chronic cough.About the same as I reported last time.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Some increase in shortness of breath and coughing requiring more frequent use of albuterol inhaler. Used to be every 2 to 3 hours. Now it is 2 puffs every hour.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea — Feeling: FairFree text: Same as last report: increased frequency of cough. Having to use albuterol more frequently.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: FairFree text: Some increase in coughing, as stated before, requiring more frequent use of albuterol inhaler.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-02-02
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-26
- 2021-03-07
- 2021-03-13
- 2021-03-20
- 2021-05-06
- 2021-08-07
-
2021-08-26
Dose 3 — Pfizer-BioNTech
-
2022-01-27
Dose 4 — Pfizer-BioNTech
- 2022-02-04
- 2022-02-04
- 2022-02-10
- 2022-02-17
- 2022-02-26
- 2022-03-05
- 2022-03-10
-
2022-04-28
Survey response — 3 months, dose 4MedDRA: Cough, Decreased appetite, Productive cough, Respiratory symptom, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Had URI type of symptoms with clear rhinorrea. Some coughing and expectoration of phlegm. No fever or chills. Some decrease in appetite. No nausea or vomiting.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-13
Dose 5 — Pfizer-BioNTech
-
2022-07-28
Survey response — 6 months, dose 4MedDRA: Computerised tomogram abnormal, Culture positive, Office visit, Productive cough, Pseudomonas infection, Respiratory tract infection, Upper respiratory tract infection — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: URI infection with more frequent cough and productive sputum. CT chest: Abnormal findings suggestive of respiratory infection. Treated for 10 days of oral cephalosporin. Follow up CT some improvement. Culture positive for mucoid pseudomonas. ID cons. · Healthcare visit (other): Visit with Infectious Disease consultant.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-28
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2022-07-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-12
- 2022-08-19
- 2023-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-08-26 | Pfizer-BioNTech | No |
| 4 | 2022-01-27 | Pfizer-BioNTech | No |
| 5 | 2022-07-13 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Slight increase in the frequency of my chronic cough.About the same as I reported last time.
Systemic reaction (other): Some increase in shortness of breath and coughing requiring more frequent use of albuterol inhaler. Used to be every 2 to 3 hours. Now it is 2 puffs every hour.
Systemic reaction (other): Same as last report: increased frequency of cough. Having to use albuterol more frequently.
Systemic reaction (other): Some increase in coughing, as stated before, requiring more frequent use of albuterol inhaler.
Release 11 — 3 months, dose 4
Symptoms: Had URI type of symptoms with clear rhinorrea. Some coughing and expectoration of phlegm. No fever or chills. Some decrease in appetite. No nausea or vomiting.
Release 12 — 6 months, dose 4
Symptoms: URI infection with more frequent cough and productive sputum. CT chest: Abnormal findings suggestive of respiratory infection. Treated for 10 days of oral cephalosporin. Follow up CT some improvement. Culture positive for mucoid pseudomonas. ID cons. cut off by CDC
Healthcare visit (other): Visit with Infectious Disease consultant.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Computerised tomogram abnormal | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Culture positive | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pseudomonas infection | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release